Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

A signature for early-stage heart failure could improve diagnosis and prevent disease progression

September 30, 2014 – 8:53 am | Edit Post

Metabolic signature identifies early heart failure in mice.

ZMapp Ebola Drug Production Set for Texas, Possibly North Carolina

September 30, 2014 – 5:00 am | Edit Post

A federal initiative to ensure that the United States can respond to biological threats at home will be put to the test in response to the Ebola outbreak in West Africa. A Texas site is preparing to…

[[Click headline to continue reading.]]

Salk scientists receive $3 million for BRAIN Initiative grant

September 29, 2014 – 5:00 pm | Edit Post

LA JOLLA—Joseph Ecker, a Salk professor and Howard Hughes Medical Institute investigator, and Margarita Behrens, Salk staff scientist, have been named recipients in the 2014 round of grants from the National Institutes of Health (NIH) through the BRAIN (Brain Research through Advancing Innovative Neurotechnologies) Initiative for leading-edge work in neuroscience. The grant, announced September 30, provides more than $3 million in funding to the Salk scientists over three years.

A “Frenemy” in Parkinson’s Disease Takes to Crowdsourcing

September 29, 2014 – 1:53 pm | Edit Post

Researchers have found that a key neuronal protein called alpha-synuclein normally gathers in synapses, where aggregates of it help regulate neurotransmissions. In overabundance, though, a-synuclein can choke off communication altogether, leading to neuronal death and related diseases.

New insights into how the heart forms may help identify heart defects

September 29, 2014 – 11:22 am | Edit Post

Cdc42 controls embryonic heart formation.

Daiichi Sankyo Offers $315M Up Front to Get Ambit and Leukemia Drug

September 29, 2014 – 10:09 am | Edit Post

Japan’s Daiichi Sankyo has agreed to acquire San Diego cancer drug developer Ambit Biosciences (NASDAQ: AMBI) for $315 million in cash, with additional milestone payments that could bring the total…
[[Click headline to continue reading.]]

Algae as biofuel focus of summit

September 29, 2014 – 6:50 am | Edit Post

Algae research summit conference returns to the epicenter of algae biotechnology.

Helping Teens Find a Path to STEM Careers

September 29, 2014 – 12:00 am | Edit Post

The new Science Saturday program introduces high school students to biomedical research at TSRI.

Surprising Diversity of Antibody Family Provides Clues for HIV Vaccine Design

September 29, 2014 – 12:00 am | Edit Post

A team from the Burton and Wilson labs has described how a single family of antibodies has evolved remarkably diverse structures to attack a vulnerable site on HIV.

TSRI Scientists Awarded $7.9 Million to Develop Artificial Immune System

September 29, 2014 – 12:00 am | Edit Post

The projects are being led by Tom Kodadek and Brian Paegel at Scripps Florida and Floyd Romesberg at Scripps California.